Invitation to market update in Moberg Pharma on November 25[th]
STOCKHOLM, November 23[rd], 2020 - On November 25[th], 2020, at 02:00 am (CET), investors, analysts and journalists are invited to participate in a digital company presentation. Moberg pharma recently announced its intention to distribute its subsidiary OncoZenge through a Lex ASEA distribution before listing the company on Nasdaq First North Growth Market, as well as securing financing both for OncoZenge and Moberg Pharma.The teleconference will be hosted by Moberg Pharmas’s CEO Anna Ljung and Chairman of the Board Peter Wolpert. The presentation will be held in Swedish. Date: